GoodRx 

Antitrust Allegations by Independent Pharmacies: Independent pharmacies in Pennsylvania are seeking to consolidate various class-action lawsuits against GoodRx and major pharmacy benefit managers (PBMs), including CVS Caremark and Express Scripts, in a federal court in Rhode Island. These pharmacies allege that the companies colluded to suppress reimbursement rates for generic drugs, severely impacting the profitability and sustainability of smaller, local pharmacies.

FTC Fine Over Data Sharing Violations: The Federal Trade Commission (FTC) imposed a $1.5 million fine on GoodRx for illegally sharing users’ sensitive health data, including prescription information, with advertising giants like Facebook and Google. The company failed to obtain proper user consent, breaching the Health Breach Notification Rule and raising serious privacy issues.

Misleading Claims About Prescription Savings: GoodRx has come under fire for exaggerating the discounts users could obtain on medications. Several users reported discrepancies between advertised and actual prices, resulting in significantly lower savings than promoted, which misled customers relying on the platform for affordable medications.

User Data Exploitation and Privacy Breach: GoodRx allegedly amassed large amounts of user data under the pretense of enhancing user experience. However, this data was reportedly sold to third-party advertisers without clear user consent, violating privacy agreements and eroding consumer trust.

Deceptive Ownership Disclosures: Raj Beri, who was linked to GoodRx, publicly portrayed himself as just an investor, while in reality, he held ownership and was a key decision-maker. This misrepresentation was part of a broader PR strategy aimed at concealing his active involvement in the company’s controversial operations.